IMVT

30.32

3.06% 0.90

Handel nachbörslich: 28.81 -1.51 -4.98%

Immunovant Inc (IMVT)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt IMVT? Forum Prognose

Schlusskurs vom Vortag:

$29.42

Offen:

$29.17

24-Stunden-Volumen:

684.37K

Relative Volume:

0.82

Marktkapitalisierung:

$4.44B

Einnahmen:

Nettoeinkommen (Verlust:

$-272.55M

KGV:

-15.71

EPS:

-1.93

Netto-Cashflow:

$-243.55M

1W Leistung:

+1.47%

1M Leistung:

-0.62%

6M Leistung:

+5.06%

1J Leistung:

-10.80%

1-Tages-Spanne:

$28.45

$30.38

1-Wochen-Bereich:

$28.28

$30.38

52-Wochen-Spanne:

$24.67

$45.58

Immunovant Inc Stock (IMVT) Company Profile

Firmenname

Immunovant Inc

Sektor

Healthcare (1182)

Branche

Biotechnology (671)

Telefon

917-580-3099

Adresse

320 WEST 37TH STREET, NEW YORK, NY

Mitarbeiter

207

Twitter

Nächster Verdiensttermin

2024-11-07

Neueste SEC-Einreichungen

IMVT's Discussions on Twitter

Immunovant Inc Stock (IMVT) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2024-02-15	Eingeleitet	Wolfe Research	Outperform
2023-12-12	Eingeleitet	Deutsche Bank	Buy
2023-10-13	Hochstufung	UBS	Neutral → Buy
2023-09-26	Hochstufung	Raymond James	Mkt Perform → Outperform
2023-05-01	Eingeleitet	BofA Securities	Buy
2023-04-25	Eingeleitet	Citigroup	Buy
2023-03-31	Eingeleitet	Piper Sandler	Overweight
2023-03-30	Eingeleitet	Stifel	Buy
2023-02-15	Eingeleitet	Cantor Fitzgerald	Overweight
2023-02-13	Hochstufung	Guggenheim	Neutral → Buy
2023-01-03	Hochstufung	Wells Fargo	Equal Weight → Overweight
2022-09-26	Herabstufung	UBS	Buy → Neutral
2021-12-08	Eingeleitet	Wells Fargo	Equal Weight
2021-08-03	Herabstufung	Robert W. Baird	Outperform → Neutral
2021-08-02	Herabstufung	Credit Suisse	Neutral → Underperform
2021-06-01	Herabstufung	Guggenheim	Buy → Neutral
2021-06-01	Herabstufung	Stifel	Buy → Hold
2020-10-28	Eingeleitet	UBS	Buy
2020-10-12	Eingeleitet	Guggenheim	Buy
2020-10-08	Eingeleitet	Stifel	Buy
2020-10-02	Eingeleitet	Credit Suisse	Outperform
2020-08-26	Bestätigt	H.C. Wainwright	Buy
2020-08-25	Eingeleitet	Raymond James	Outperform
2020-07-29	Eingeleitet	H.C. Wainwright	Buy
2020-02-24	Eingeleitet	SVB Leerink	Outperform

Alle ansehen

Immunovant Inc Aktie (IMVT) Neueste Nachrichten

Nov 04, 2024

Emerald Mutual Fund Advisers Trust Has $5.24 Million Holdings in Immunovant, Inc. (NASDAQ:IMVT) - MarketBeat

Nov 04, 2024

Nov 02, 2024

Where are the Opportunities in (IMVT) - Stock Traders Daily

Nov 02, 2024

Analysts Set Immunovant, Inc. (NASDAQ:IMVT) Price Target at $48.10 - Defense World

Nov 02, 2024

Immunovant, Inc. (NASDAQ:IMVT) Position Boosted by abrdn plc - MarketBeat

Nov 02, 2024

Oct 30, 2024

Brokerages Set Immunovant, Inc. (NASDAQ:IMVT) Price Target at $48.10 - MarketBeat

Oct 30, 2024

Oct 29, 2024

Immunovant Announces Oral Presentation of Late Breaking Abstract for Phase 2 Graves' Disease Clinical Data at the 2024 American Thyroid Association (ATA) Annual Meeting - The Manila Times

Oct 29, 2024

Immunovant Announces Oral Presentation of Late Breaking Abstract for Phase 2 Graves’ Disease Clinical Data at the 2024 American Thyroid Association (ATA) Annual Meeting - ForexTV.com

Oct 29, 2024

Oct 26, 2024

Immunovant's chief medical officer sells $94,171 in stock By Investing.com - Investing.com Canada

Oct 26, 2024

Oct 25, 2024

Immunovant CTO Jay Stout sells $80,912 in stock By Investing.com - Investing.com Canada

Oct 25, 2024

Immunovant's chief legal officer Mark Levine sells shares worth $128,780 By Investing.com - Investing.com Australia

Oct 25, 2024

Immunovant's chief legal officer Mark Levine sells shares worth $128,780 - Investing.com

Oct 25, 2024

Oct 19, 2024

Immunovant CFO Eva Renee Barnett sells $94,172 in stock By Investing.com - Investing.com Australia

Oct 19, 2024

Immunovant's chief medical officer William Macias sells $91,782 in stock - Investing.com India

Oct 19, 2024

Immunovant's chief legal officer sells $82,339 in stock By Investing.com - Investing.com Australia

Oct 19, 2024

Immunovant's chief legal officer sells $82,339 in stock - Investing.com India

Oct 19, 2024

Exchange Traded Concepts LLC Buys 9,438 Shares of Immunovant, Inc. (NASDAQ:IMVT) - Defense World

Oct 19, 2024

Immunovant CFO Eva Renee Barnett sells $94,172 in stock - Investing.com

Oct 19, 2024

Immunovant CEO Peter Salzmann sells $261,845 in shares By Investing.com - Investing.com Australia

Oct 19, 2024

Oct 18, 2024

Immunovant CEO Peter Salzmann sells $261,845 in shares - Investing.com

Oct 18, 2024

Immunovant, Inc. (NASDAQ:IMVT) Insider Sells $91,782.52 in Stock - MarketBeat

Oct 18, 2024

Oct 16, 2024

Immunovant (NASDAQ:IMVT) Is In A Good Position To Deliver On Growth Plans - Simply Wall St

Oct 16, 2024

IMVT (Immunovant Inc) has impressive results - US Post News

Oct 16, 2024

Oct 15, 2024

Raymond James gives an Outperform recommendation for Immunovant Inc (IMVT) - Knox Daily

Oct 15, 2024

Analyzing Ratios: Immunovant Inc (IMVT)’s Financial Story Unveiled - The Dwinnex

Oct 15, 2024

Oct 14, 2024

Immunovant: Switching Lead Candidates Increases Risk (NASDAQ:IMVT) - Seeking Alpha

Oct 14, 2024

The Manufacturers Life Insurance Company Decreases Stake in Immunovant, Inc. (NASDAQ:IMVT) - MarketBeat

Oct 14, 2024

Oct 12, 2024

Immunovant CEO sells over $131k in company stock By Investing.com - Investing.com Australia

Oct 12, 2024

Immunovant CFO sells over $150k in company stock By Investing.com - Investing.com Australia

Oct 12, 2024

Oct 11, 2024